Patients of the Office of the Vice President’s E-Konsulta program may now receive the breakthrough COVID-19 pill Molnupiravir, the OVP said.
“MOLNUPIRAVIR is now available for our patients who may be prescribed to take them under our Bayanihan E-Konsulta Program,” the Office of the Vice President wrote on its official Facebook page.
Robredo’s office announced that it had signed a Memorandum of Agreement with QualiMed Health Network to provide assistance to patients prescribed with Molnupiravir, an oral pill for the treatment of mild to moderate cases of COVID-19.
Molnupiravir was developed by Merck and Ridgeback Biotherapeutics and was reported to cut the risk of hospitalization or death by half.
The Food and Drug Administration has issued a compassionate special permit for the use of molnupiravir to several hospitals, including those under the QualiMed network.
VP Leni’s office said that it will issue a guarantee letter under its special medical assistance program to qualified patients referred by volunteer doctors at Bayanihan E-Konsulta. QualiMed facilities will further assess and prescribe the drug to the patient, the OVP added.
“We are truly humbled and grateful to the QualiMed Health Network for trusting us with this partnership, helping us extend our reach in delivering aid to more of our kababayans in need,” the OVP wrote.
The first shipment of molnupiravir arrived in the Philippines last week, the first country in Southeast Asia to receive its supply of the drug.